Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease DiagnosticsGlobeNewsWire • 06/08/22
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator's CircleGlobeNewsWire • 03/21/22
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology MicroarrayGlobeNewsWire • 03/08/22
Quotient Limited (QTNT) CEO Manuel Mendez on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/08/22
Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business UpdateGlobeNewsWire • 02/08/22
Nuformix hails progress partner is making with reformulated anti-sickness drugProactive Investors • 02/08/22
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/03/22
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference CallGlobeNewsWire • 01/31/22
Quotient (QTNT) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 01/31/22
Quotient (QTNT) Could Find Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 12/16/21
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking ProgressGlobeNewsWire • 12/15/21
Is the Options Market Predicting a Spike in Quotient Limited (QTNT) Stock?Zacks Investment Research • 11/22/21
Quotient Limited to Participate in the Jefferies London Healthcare ConferenceGlobeNewsWire • 11/12/21
Quotient Limited (QTNT) CEO Manuel Méndez on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured NotesGlobeNewsWire • 10/14/21
Is the Options Market Predicting a Spike in Quotient (QTNT) Stock?Zacks Investment Research • 10/04/21